Loading clinical trials...
Loading clinical trials...
Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy- a Double-Blind Placebo-Controlled Study
Conditions
Interventions
Escitalopram
Locations
1
Israel
Sourasky Medical Center
Tel Aviv, Israel
Start Date
December 1, 2007
Primary Completion Date
October 1, 2008
Completion Date
October 1, 2008
Last Updated
April 1, 2008
NCT04965012
NCT02955329
NCT02011516
NCT01574183
NCT00875836
NCT00373503
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions